Otsuka (OTCMKTS:OTSKY) Shares Gap Up – What’s Next?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKYGet Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $35.35, but opened at $36.71. Otsuka shares last traded at $36.2545, with a volume of 1,631 shares trading hands.

Otsuka Trading Up 2.8%

The company has a quick ratio of 1.65, a current ratio of 2.21 and a debt-to-equity ratio of 0.05. The company has a market capitalization of $39.04 billion, a P/E ratio of 14.59, a P/E/G ratio of 2.54 and a beta of 0.02. The firm’s 50-day moving average price is $36.86 and its 200 day moving average price is $35.23.

Otsuka (OTCMKTS:OTSKYGet Free Report) last released its quarterly earnings results on Friday, July 31st. The company reported $0.70 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a return on equity of 12.86% and a net margin of 15.50%.The business had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. As a group, equities research analysts predict that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 earnings per share for the current year.

About Otsuka

(Get Free Report)

Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products group whose businesses span pharmaceuticals, nutraceuticals and consumer health products, as well as related medical and chemical activities. The company operates primarily through subsidiaries including Otsuka Pharmaceutical Co, Ltd. and serves customers in Japan and international markets.

Otsuka’s pharmaceutical operations focus on prescription medicines in areas such as psychiatry, oncology, nephrology, cardiovascular disease and several other therapeutic fields.

Featured Stories

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.